Catalyst Pharmaceuticals, Inc. (CPRX)
31.16
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
31.16
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Total Liabilities (Quarterly) : 134.91M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 274.86M |
| Inovio Pharmaceuticals, Inc. | 51.59M |
| United Therapeutics Corp. | 813.10M |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Agios Pharmaceuticals, Inc. | 75.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.148B |
| Shareholders Equity (Quarterly) | 1.013B |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.00% |